FDA Supercharges Oversight: AI Tools Boost Regulatory Data Analysis
The FDA is expanding its AI capabilities with new tools to enhance data analysis and regulatory processes.
The FDA is expanding its AI capabilities with new tools to enhance data analysis and regulatory processes.
The FDA introduces one-day inspectional assessments to enhance its oversight of the medical device industry.